{
  "session_start": "2025-12-11T11:58:03.701893",
  "conversations": [
    {
      "timestamp": "2025-12-11T11:58:22.570983",
      "type": "user_message",
      "content": "I want to launch a trial for my new Ulcerative Colitis treatment, what are typical eligibility criteria?"
    },
    {
      "timestamp": "2025-12-11T11:58:25.551021",
      "type": "tool_call",
      "tool_name": "search_trials",
      "parameters": {
        "condition": "Ulcerative Colitis",
        "max_results": 5
      },
      "result_preview": {
        "_preview": "List with 5 items",
        "_sample": [
          {
            "nctId": "NCT00745329",
            "title": "The Effect of Infliximab on Sperm Quality",
            "acronym": "",
            "status": "UNKNOWN",
            "phases": [],
            "studyType": "OBSERVATIONAL",
            "conditions": [
              "Crohn's Disease",
              "Ulcerative Colitis"
            ],
            "interventions": [
              {
                "type": "OTHER",
                "name": "sperm quality test",
                "description": "All participants will undergo sequential sperm quality tests and blood tests"
              }
            ],
            "sponsor": "Tel-Aviv Sourasky Medical Center",
            "sponsorClass": "OTHER_GOV",
            "enrollment": {
              "count": 100,
              "type": "ESTIMATED"
            },
            "dates": {
              "start": "2008-10",
              "startType": "",
              "completion": "",
              "completionType": "",
              "primaryCompletion": "",
              "firstPosted": "2008-09-03",
              "lastUpdated": "2008-09-03",
              "firstSubmit": "2008-09-01"
            },
            "eligibility": {
              "criteria": "Inclusion Criteria:\n\n* Male above the age of 18\n* Capable of giving informed consent\n* Diagnosed with IBD at least 3 months\n* Patients that are going to start a treatment with on of the following groups: 5ASA, Azathioprines, infliximab or ADAlimumab\n* Patients that are treated with therapies mentioned in article 4 for at least 3 months\n\nExclusion Criteria:\n\n* Male younger than 18",
              "sex": "MALE",
              "minAge": "18 Years",
              "maxAge": "",
              "stdAges": [
                "ADULT",
                "OLDER_ADULT"
              ],
              "healthyVolunteers": true
            },
            "locations": []
          },
          {
            "nctId": "NCT02452151",
            "title": "\"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial\"",
            "acronym": "SIMILAR",
            "status": "UNKNOWN",
            "phases": [
              "PHASE4"
            ],
            "studyType": "INTERVENTIONAL",
            "conditions": [
              "Colitis, Ulcerative",
              "Crohn's Disease"
            ],
            "interventions": [
              {
                "type": "DRUG",
                "name": "Infliximab-Biosimilar",
                "description": ""
              },
              {
                "type": "DRUG",
                "name": "Infliximab-Innovator",
                "description": ""
              }
            ],
            "sponsor": "Onze Lieve Vrouwe Gasthuis",
            "sponsorClass": "OTHER",
            "enrollment": {
              "count": 300,
              "type": "ESTIMATED"
            },
            "dates": {
              "start": "2015-08",
              "startType": "",
              "completion": "2016-09",
              "completionType": "ESTIMATED",
              "primaryCompletion": "2016-08",
              "firstPosted": "2015-05-22",
              "lastUpdated": "2015-05-22",
              "firstSubmit": "2015-05-20"
            },
            "eligibility": {
              "criteria": "Inclusion Criteria:\n\nPatients, male or female, aged above 18 years at time of enrolment will be selected from hospital databases based on appointments for Infliximab infusion as treatment for IBD. Patients are eligible for inclusion if they have an established diagnosis of ulcerative colitis or Crohn's disease, are in clinical remission and are medically treated with Infliximab for at least 12 weeks prior to inclusion.\n\nExclusion Criteria:\n\n1. Patient has an allergy or hypersensitivity to one of the components of infliximab and/or immunoglobulin products, except hypersensitivity reactions which have a positive response to hydrocortisone and thereby are under control.\n2. Patient has a current diagnosis with hepatitis B, hepatitis C or an infection with human immunodeficiency virus (HIV)-1 o",
              "sex": "ALL",
              "minAge": "18 Years",
              "maxAge": "",
              "stdAges": [
                "ADULT",
                "OLDER_ADULT"
              ],
              "healthyVolunteers": false
            },
            "locations": []
          }
        ]
      }
    },
    {
      "timestamp": "2025-12-11T11:58:34.920951",
      "type": "assistant_response",
      "content": {
        "answer": "Identified typical eligibility criteria from recent trials in Ulcerative Colitis.",
        "trials": [
          {
            "nct_id": "NCT00745329",
            "title": "The Effect of Infliximab on Sperm Quality",
            "phase": "",
            "status": "UNKNOWN",
            "sponsor": "Tel-Aviv Sourasky Medical Center",
            "enrollment": 100,
            "start_date": "2008-10",
            "completion_date": ""
          },
          {
            "nct_id": "NCT02452151",
            "title": "Efficacy and Safety of Infliximab-biosimilar Compared to Infliximab-innovator in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial",
            "phase": "PHASE4",
            "status": "UNKNOWN",
            "sponsor": "Onze Lieve Vrouwe Gasthuis",
            "enrollment": 300,
            "start_date": "2015-08",
            "completion_date": "2016-09"
          },
          {
            "nct_id": "NCT02488954",
            "title": "Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis",
            "phase": "NA",
            "status": "TERMINATED",
            "sponsor": "Rennes University Hospital",
            "enrollment": 7,
            "start_date": "2016-02-12",
            "completion_date": "2017-06-30"
          },
          {
            "nct_id": "NCT00618202",
            "title": "A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions",
            "phase": "NA",
            "status": "COMPLETED",
            "sponsor": "Roxane Laboratories",
            "enrollment": 52,
            "start_date": "2005-05",
            "completion_date": "2005-06"
          },
          {
            "nct_id": "NCT05680883",
            "title": "Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative Colitis",
            "phase": "",
            "status": "UNKNOWN",
            "sponsor": "Radboud University Medical Center",
            "enrollment": 40,
            "start_date": "2022-05-05",
            "completion_date": "2023-11-05"
          }
        ],
        "sites": [],
        "criteria": {
          "inclusion": [
            "Male or female aged above 18 years at time of enrolment",
            "Diagnosis of ulcerative colitis for at least 6 months",
            "Able to provide signed informed consent"
          ],
          "exclusion": [
            "Current diagnosis with hepatitis B, C or HIV infections",
            "Severe disease or acute severe colitis",
            "Inability to comply with study-related procedures"
          ]
        },
        "sources": [
          "NCT00745329",
          "NCT02452151",
          "NCT02488954",
          "NCT00618202",
          "NCT05680883"
        ]
      }
    },
    {
      "timestamp": "2025-12-11T12:00:15.947781",
      "type": "user_message",
      "content": "How many trials are currently recruiting for the same condition?"
    },
    {
      "timestamp": "2025-12-11T12:00:18.666112",
      "type": "tool_call",
      "tool_name": "count_trials",
      "parameters": {
        "condition": "Ulcerative Colitis",
        "status": "Recruiting"
      },
      "result_preview": {
        "count": 238,
        "is_exact": true
      }
    },
    {
      "timestamp": "2025-12-11T12:00:20.635406",
      "type": "assistant_response",
      "content": {
        "answer": "There are currently 238 recruiting trials for Ulcerative Colitis.",
        "trials": null,
        "sites": null,
        "criteria": null,
        "sources": []
      }
    },
    {
      "timestamp": "2025-12-11T12:00:40.954004",
      "type": "memory_cleared"
    }
  ]
}